Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L V Wilton

Showing results (31-40 of 40) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 40 results.
Drug Safety|January 5, 2002
Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring databaseD W Clark, D Layton, L V Wilton, et al.
BMJ (Clinical Research Ed.)|July 17, 1998
Unlicensed and off label drug use for paediatric patients. General practitioners prescribe SSRIs to children off labelR M Martin, L V Wilton, R D Mann, et al.
BMJ (Clinical Research Ed.)|October 1, 1988
Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failureC J Speirs, C T Dollery, W H Inman, et al.
British Journal of Obstetrics and Gynaecology|September 24, 1998
The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in EnglandL V Wilton, G L Pearce, R M Martin, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 17, 1998
United Kingdom experience with alendronate and oesophageal reactionsF J Mackay, L V Wilton, G L Pearce, et al.
BMJ (Clinical Research Ed.)|October 1, 1988
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoringW H Inman, N S Rawson, L V Wilton, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilanceR D Mann, L V Wilton, G L Pearce, et al.
Epilepsia|August 1, 1997
Safety of long-term lamotrigine in epilepsyF J Mackay, L V Wilton, G L Pearce, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 28, 2003
Prospective observational cohort safety study to monitor the introduction of a non-CFC formulation of salbutamol with HFA134a in EnglandP M Craig-McFeely, L V Wilton, J B Soriano, et al.
Pharmacoepidemiology and Drug Safety|July 1, 1997
A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studiesF J Mackay, N R Dunn, L V Wilton, et al.
Pageof 4

Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Drug Safety|January 5, 2002
Profiles of hepatic and dysrhythmic cardiovascular events following use of fluoroquinolone antibacterials: experience from large cohorts from the Drug Safety Research Unit Prescription-Event Monitoring databaseD W Clark, D Layton, L V Wilton, et al.
BMJ (Clinical Research Ed.)|July 17, 1998
Unlicensed and off label drug use for paediatric patients. General practitioners prescribe SSRIs to children off labelR M Martin, L V Wilton, R D Mann, et al.
BMJ (Clinical Research Ed.)|October 1, 1988
Postmarketing surveillance of enalapril. II: Investigation of the potential role of enalapril in deaths with renal failureC J Speirs, C T Dollery, W H Inman, et al.
British Journal of Obstetrics and Gynaecology|September 24, 1998
The outcomes of pregnancy in women exposed to newly marketed drugs in general practice in EnglandL V Wilton, G L Pearce, R M Martin, et al.
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|July 17, 1998
United Kingdom experience with alendronate and oesophageal reactionsF J Mackay, L V Wilton, G L Pearce, et al.
BMJ (Clinical Research Ed.)|October 1, 1988
Postmarketing surveillance of enalapril. I: Results of prescription-event monitoringW H Inman, N S Rawson, L V Wilton, et al.
Pharmacoepidemiology and Drug Safety|April 10, 2004
Prescription-event monitoring (PEM) in 1996-a method of non-interventional observational cohort pharmacovigilanceR D Mann, L V Wilton, G L Pearce, et al.
Epilepsia|August 1, 1997
Safety of long-term lamotrigine in epilepsyF J Mackay, L V Wilton, G L Pearce, et al.
International Journal of Clinical Pharmacology and Therapeutics|February 28, 2003
Prospective observational cohort safety study to monitor the introduction of a non-CFC formulation of salbutamol with HFA134a in EnglandP M Craig-McFeely, L V Wilton, J B Soriano, et al.
Pharmacoepidemiology and Drug Safety|July 1, 1997
A comparison of fluvoxamine, fluoxetine, sertraline and paroxetine examined by observational cohort studiesF J Mackay, N R Dunn, L V Wilton, et al.
Pageof 4